Detalhe da pesquisa
1.
Comparing the safety and efficacy of ruxolitinib in patients with Dynamic International Prognostic Scoring System low-, intermediate-1-, intermediate-2-, and high-risk myelofibrosis in JUMP, a Phase 3b, expanded-access study.
Hematol Oncol
; 39(4): 558-566, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34224180
2.
The myeloid sarcoma treated by Venetoclax with hypomethylating agent followed by stem cell transplantation: rare case report.
BMC Womens Health
; 21(1): 184, 2021 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33933047
3.
Primary analysis of JUMP, a phase 3b, expanded-access study evaluating the safety and efficacy of ruxolitinib in patients with myelofibrosis, including those with low platelet counts.
Br J Haematol
; 189(5): 888-903, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32017044
4.
Impact of age and comorbidities on the efficacy of FC and FCR regimens in chronic lymphocytic leukemia.
Ann Hematol
; 97(11): 2153-2161, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-29946909
5.
Bosutinib is active in chronic phase chronic myeloid leukemia after imatinib and dasatinib and/or nilotinib therapy failure.
Blood
; 119(15): 3403-12, 2012 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-22371878
6.
Definitions, methodological and statistical issues for phase 3 clinical trials in chronic myeloid leukemia: a proposal by the European LeukemiaNet.
Blood
; 119(25): 5963-71, 2012 Jun 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-22508936
7.
Bosutinib efficacy and safety in chronic phase chronic myeloid leukemia after imatinib resistance or intolerance: Minimum 24-month follow-up.
Am J Hematol
; 89(7): 732-42, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24711212
8.
Shift of N-MYC Oncogene Expression in AML Patients Carrying the FLT3-ITD Mutation.
Pathophysiology
; 30(3): 296-313, 2023 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37606386
9.
Strategies to Circumvent the Side-Effects of Immunotherapy Using Allogeneic CAR-T Cells and Boost Its Efficacy: Results of Recent Clinical Trials.
Front Immunol
; 12: 780145, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34975869
10.
Ovarian tissue cryopreservation in prepubertal patients with oncological diseases: multidisciplinary approach and outcomes.
J Matern Fetal Neonatal Med
; 34(14): 2391-2398, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31500478
11.
Obinutuzumab plus fludarabine and cyclophosphamide in previously untreated, fit patients with chronic lymphocytic leukemia: a subgroup analysis of the GREEN study.
Leukemia
; 34(2): 441-450, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31455851
12.
Rapid Efficacy of Gemtuzumab Ozogamicin in Refractory AML Patients with Pulmonary and Kidney Failure.
Biology (Basel)
; 9(2)2020 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32050707
13.
The EUTOS long-term survival (ELTS) score is superior to the Sokal score for predicting survival in chronic myeloid leukemia.
Leukemia
; 34(8): 2138-2149, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32601376
14.
The biological basis and clinical symptoms of CAR-T therapy-associated toxicites.
Cell Death Dis
; 9(9): 897, 2018 09 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30181581
15.
VEGFR2-specific FnCAR effectively redirects the cytotoxic activity of T cells and YT NK cells.
Oncotarget
; 9(10): 9021-9029, 2018 Feb 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29507671
16.
Lenalidomide maintenance therapy in previously treated chronic lymphocytic leukaemia (CONTINUUM): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Haematol
; 4(11): e534-e543, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28958469
17.
Standard of care and direct medical costs of the treatment of chronic lymphocytic leukemia among the adult population in Ukraine, Russia, and Kazakhstan: data from the LEUKOSPECT study.
Cancer Manag Res
; 9: 387-395, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28919818
18.
Phase III, randomized study of ofatumumab versus physicians' choice of therapy and standard versus extended-length ofatumumab in patients with bulky fludarabine-refractory chronic lymphocytic leukemia.
Leuk Lymphoma
; 57(9): 2037-46, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-26784000
19.
Functional properties of bone marrow derived multipotent mesenchymal stromal cells are altered in heart failure patients, and could be corrected by adjustment of expansion strategies.
Aging (Albany NY)
; 7(1): 14-25, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25606985
20.
Transcriptional changes in bone marrow stromal cells of patients with heart failure.
Cell Cycle
; 13(9): 1495-500, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24626177